{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:33:58Z","timestamp":1793464438119,"version":"4.5.0"},"reference-count":34,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Despite concerns about the toxicity of allogeneic hematopoietic cell transplantation (alloHCT) in older patients, prospective data characterizing prevalence or risk stratification for geriatric morbidity such as disability or frailty are limited. We prospectively assessed the prognostic impact of the novel composite health assessment risk model (CHARM), a score established to predict 1-year nonrelapse mortality (NRM), among 1105 patients aged \u226560 years enrolled on the Bone Marrow Transplant Clinical Trials Network Study 1704. Secondary end points were assessed post-alloHCT at day 100 (D100), D180, and D365 in multivariable models adjusted with predetermined clinical variables. Among alloHCT survivors, the prevalence of disability by instrumental activities of daily living (IADL), frailty by the Physical Frailty Phenotype, and physical function impairment by Patient Reported Measurement Information System (PROMIS) was highest at D100 and lower on D180 and D365. Higher CHARM scores were independently associated with greater disability (coefficient, \u22120.64; 95% confidence interval [CI], \u22120.85 to \u22120.43; P&amp;lt; .001), increased frailty (coefficient, 0.19; CI, 0.081-0.31; P&amp;lt; .001), worse PROMIS physical function, greater PROMIS depression, increased serious organ toxicity by D100, more cognitive decline at D100, and higher mortality after acute graft-versus-host disease (GVHD) but not significantly associated with PROMIS anxiety or acute GVHD. Higher CHARM scores predicted worse disability-free survival (odds ratio [OR], 2.03; CI, 1.66-2.48; P&amp;lt; .001) and lower frailty-free survival (OR, 2.00; CI, 1.61-2.49). In summary, CHARM is an independent prognostic scoring system not only for NRM but also for geriatric morbidity and functional limitation\u2013free survival through 1 year after alloHCT. Pre-alloHCT CHARM is a novel tool to aid shared decision-making for older patients. This trial was registered at www.clinicaltrials.gov as #NCT03992352.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018340","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:12:49Z","timestamp":1763745169000},"page":"1657-1669","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-9607","authenticated-orcid":false,"given":"Andrew S.","family":"Artz","sequence":"first","affiliation":[{"name":"1Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Logan","sequence":"additional","affiliation":[{"name":"2Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Saber","sequence":"additional","affiliation":[{"name":"2Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Geller","sequence":"additional","affiliation":[{"name":"3The Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3476-0097","authenticated-orcid":false,"given":"Anna","family":"Bellach","sequence":"additional","affiliation":[{"name":"3The Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqun","family":"Kou","sequence":"additional","affiliation":[{"name":"4Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Wood","sequence":"additional","affiliation":[{"name":"5Lineberger Comprehensive Cancer Center, Department of Medicine, Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"McCarty","sequence":"additional","affiliation":[{"name":"6Cellular Immunotherapies and Transplant Program, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9864-7413","authenticated-orcid":false,"given":"Thomas G.","family":"Knight","sequence":"additional","affiliation":[{"name":"7Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey","family":"Runaas","sequence":"additional","affiliation":[{"name":"2Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Johnston","sequence":"additional","affiliation":[{"name":"8Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Walston","sequence":"additional","affiliation":[{"name":"9Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9082-0680","authenticated-orcid":false,"given":"Ryotaro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"1Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmita","family":"Mishra","sequence":"additional","affiliation":[{"name":"10H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Uberti","sequence":"additional","affiliation":[{"name":"11Karmanos Cancer Institute, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastoo B.","family":"Dahi","sequence":"additional","affiliation":[{"name":"12Adult Bone Marrow Transplant, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"13Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0024-9466","authenticated-orcid":false,"given":"Jennifer N.","family":"Saultz","sequence":"additional","affiliation":[{"name":"14Division of Hematology\/Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon R.","family":"McCurdy","sequence":"additional","affiliation":[{"name":"15Division of Hematology\/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Morris","sequence":"additional","affiliation":[{"name":"16The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8563-195X","authenticated-orcid":false,"given":"Philip","family":"Imus","sequence":"additional","affiliation":[{"name":"17Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5841-4105","authenticated-orcid":false,"given":"William J.","family":"Hogan","sequence":"additional","affiliation":[{"name":"18Division of Hematology (W10), Mayo Clinic Rochester, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9625-1178","authenticated-orcid":false,"given":"Kalyan","family":"Nadiminti","sequence":"additional","affiliation":[{"name":"19Division of Hematology, Oncology and Palliative Care, Carbone Cancer Center, University of Wisconsin Hospitals and Clinics, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2513-0533","authenticated-orcid":false,"given":"Vijaya Raj","family":"Bhatt","sequence":"additional","affiliation":[{"name":"20Division of Hematology-Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE"},{"name":"21Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Olin","sequence":"additional","affiliation":[{"name":"22Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Maakaron","sequence":"additional","affiliation":[{"name":"23Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Sobecks","sequence":"additional","affiliation":[{"name":"24Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wall","sequence":"additional","affiliation":[{"name":"25Division of Hematology, The Ohio State University, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Mattila","sequence":"additional","affiliation":[{"name":"4Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey","family":"Protz","sequence":"additional","affiliation":[{"name":"4Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7731-759X","authenticated-orcid":false,"given":"Steven M.","family":"Devine","sequence":"additional","affiliation":[{"name":"4Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Horowitz","sequence":"additional","affiliation":[{"name":"2Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5260-1981","authenticated-orcid":false,"given":"Mohamed L.","family":"Sorror","sequence":"additional","affiliation":[{"name":"26Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"27Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"6","key":"2026030916213797700_bib1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41409-022-01650-5","article-title":"Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis","volume":"57","author":"Maakaron","year":"2022","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"2026030916213797700_bib2","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1158\/1078-0432.CCR-23-3673","article-title":"Improvements in posttransplant outcomes over two decades in older patients with acute myeloid leukemia in the EBMT ALWP study","volume":"30","author":"Bazarbachi","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2026030916213797700_bib3","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","article-title":"Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States","volume":"130","author":"Muffly","year":"2017","journal-title":"Blood"},{"issue":"17","key":"2026030916213797700_bib4","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.2011.1558","article-title":"Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies","volume":"306","author":"Sorror","year":"2011","journal-title":"JAMA"},{"issue":"13","key":"2026030916213797700_bib5","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/bloodadvances.2025015793","article-title":"Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704","volume":"9","author":"Sorror","year":"2025","journal-title":"Blood Adv"},{"issue":"1","key":"2026030916213797700_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41409-020-01001-2","article-title":"Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation","volume":"56","author":"Lin","year":"2021","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"2026030916213797700_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/bloodadvances.2018028241","article-title":"Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults","volume":"3","author":"Lin","year":"2019","journal-title":"Blood Adv"},{"issue":"6","key":"2026030916213797700_bib8","first-page":"309.e1","article-title":"Patterns and predictors of functional decline after allogeneic hematopoietic cell transplantation in older adults","volume":"28","author":"Huang","year":"2022","journal-title":"Transpl Cell Ther"},{"issue":"5","key":"2026030916213797700_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41409-017-0021-4","article-title":"Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis","volume":"53","author":"Deschler","year":"2018","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"2026030916213797700_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jgo.2021.08.008","article-title":"Serial frailty assessments following allogeneic stem cell transplant in older adults: A pilot study","volume":"13","author":"Ombres","year":"2022","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"2026030916213797700_bib11","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"2026030916213797700_bib12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/geronj\/36.4.428","article-title":"The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire","volume":"36","author":"Fillenbaum","year":"1981","journal-title":"J Gerontol"},{"issue":"4","key":"2026030916213797700_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"2026030916213797700_bib14","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2026030916213797700_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"2026030916213797700_bib16","author":"Rubin","year":"1987"},{"issue":"23","key":"2026030916213797700_bib17","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the disease risk index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"issue":"13","key":"2026030916213797700_bib18","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/jama.2018.12621","article-title":"From lifespan to healthspan","volume":"320","author":"Olshansky","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"2026030916213797700_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11357-018-0036-9","article-title":"How healthy is the healthspan concept?","volume":"40","author":"Kaeberlein","year":"2018","journal-title":"Geroscience"},{"issue":"3","key":"2026030916213797700_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbmt.2012.11.006","article-title":"Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients","volume":"19","author":"Muffly","year":"2013","journal-title":"Biol Blood Marrow Transpl"},{"key":"2026030916213797700_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jocn.2017.08.039","article-title":"Minimum clinically important difference of Montreal Cognitive Assessment in aneurysmal subarachnoid hemorrhage patients","volume":"46","author":"Wong","year":"2017","journal-title":"J Clin Neurosci"},{"issue":"1","key":"2026030916213797700_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/bmt.2012.95","article-title":"Practice variation in physician referral for allogeneic hematopoietic cell transplantation","volume":"48","author":"Pidala","year":"2013","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"2026030916213797700_bib23","doi-asserted-by":"crossref","first-page":"e2433145","DOI":"10.1001\/jamanetworkopen.2024.33145","article-title":"Use of hematopoietic cell transplant for hematologic cancers by race, ethnicity, and age","volume":"7","author":"Hahn","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"suppl 4","key":"2026030916213797700_bib24","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2458-11-S4-S3","article-title":"Use of The International Classification of Functioning, Disability and Health (ICF) as a conceptual framework and common language for disability statistics and health information systems","volume":"11","author":"Kostanjsek","year":"2011","journal-title":"BMC Public Health"},{"issue":"19","key":"2026030916213797700_bib25","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1200\/JCO.23.02536","article-title":"Prevalence and cancer-specific patterns of functional disability among US cancer survivors, 2017-2022","volume":"42","author":"Cao","year":"2024","journal-title":"J Clin Oncol"},{"issue":"19","key":"2026030916213797700_bib26","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1001\/jama.2022.4798","article-title":"Effect of early vs standard approach to tracheostomy on functional outcome at 6 months among patients with severe stroke receiving mechanical ventilation: The SETPOINT2 randomized clinical trial","volume":"327","author":"Bosel","year":"2022","journal-title":"JAMA"},{"issue":"16","key":"2026030916213797700_bib27","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","article-title":"Effect of aspirin on disability-free survival in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"issue":"25","key":"2026030916213797700_bib28","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"issue":"8","key":"2026030916213797700_bib29","doi-asserted-by":"crossref","first-page":"e198398","DOI":"10.1001\/jamanetworkopen.2019.8398","article-title":"Global incidence of frailty and prefrailty among community-dwelling older adults: a systematic review and meta-analysis","volume":"2","author":"Ofori-Asenso","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2026030916213797700_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2318-11-47","article-title":"Recent trends in chronic disease, impairment and disability among older adults in the United States","volume":"11","author":"Hung","year":"2011","journal-title":"BMC Geriatr"},{"issue":"8","key":"2026030916213797700_bib31","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/jgs.18483","article-title":"A study of physical resilience and aging (SPRING): Conceptual framework, rationale, and study design","volume":"71","author":"Walston","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"2026030916213797700_bib32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamainternmed.2014.7889","article-title":"Functional trajectories among older persons before and after critical illness","volume":"175","author":"Ferrante","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"22","key":"2026030916213797700_bib33","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/bloodadvances.2019000790","article-title":"Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults","volume":"3","author":"Derman","year":"2019","journal-title":"Blood Adv"},{"issue":"26","key":"2026030916213797700_bib34","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.23.00933","article-title":"Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update","volume":"41","author":"Dale","year":"2023","journal-title":"J Clin Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/5\/1657\/2506258\/blooda_adv-2025-018340-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/5\/1657\/2506258\/blooda_adv-2025-018340-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:21:46Z","timestamp":1773087706000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/5\/1657\/548338\/CHARM-is-prognostic-of-geriatric-morbidity-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018340","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,10]]},"published":{"date-parts":[[2026,2,27]]}}}